Internal Medicine, Gastroenterology · Omaha, NE
NPI
1013194414
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
8901 Indian Hills Dr, Suite 200
Omaha, NE, 68114
Phone (402) 397-7057
Groups this clinician bills Medicare through
Medicare paid, 2024
$464K
22,642 services
Medicare patients, 2024
651
Average age 73
Drug cost, 2024
$1.7M
1,607 prescriptions
Company payments, 2025
$2,232
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc A Scheer was code J3380 (injection, vedolizumab, intravenous, 1 mg), 15,000 times for 40 patients. In total Marc A Scheer billed 22,642 services in 63 codes, and Medicare paid $464K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 15,000 | 40 | $17.50 | $262K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,520 | 28 | $25.03 | $63K |
| 45380 Lower GI Endoscopy - Other | Facility | 185 | 185 | $122.81 | $23K |
| 99213 Office E&M - Established | Office | 121 | 106 | $61.21 | $7,406 |
| 43239 Upper GI Endoscopy | Facility | 91 | 86 | $73.66 | $6,703 |
| 45385 Colonoscopy - Lesion Removal | Facility | 81 | 81 | $186.80 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 80 | 49 | $57.40 | $4,592 |
| 96365 Intravenous Infusion, Hydration | Office | 52 | 43 | $43.82 | $2,279 |
| 99222 Hospital E&M - Initial | Facility | 48 | 47 | $94.69 | $4,545 |
| 99214 Office E&M - Established | Office | 47 | 41 | $84.49 | $3,971 |
| 96413 Chemotherapy Administration | Office | 43 | 37 | $90.01 | $3,870 |
| 43450 Digestive/Gastrointestinal | Facility | 30 | 29 | $26.52 | $796 |
| 99204 Office E&M - New | Office | 29 | 29 | $111.42 | $3,231 |
| 36415 Venipuncture Blood Collection | Office | 27 | 21 | $8.65 | $234 |
| 43235 Upper GI Endoscopy | Facility | 24 | 23 | $62.07 | $1,490 |
By year: 2022 $287K for 11,677 services; 2023 $344K for 14,816 services; 2024 $464K for 22,642 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 21 | $8.65 | $234 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc A Scheer prescribed most often to Medicare patients was Pantoprazole Sodium, with 296 prescriptions and refills. In total Marc A Scheer wrote 1,607 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 296 | 506 | 71 | $3,212 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 183 | 189 | 179 | $3,663 |
| Omeprazole Generic | 173 | 342 | 46 | $2,247 |
| Sucralfate Generic | 104 | 120 | 25 | $8,384 |
| Famotidine Generic | 59 | 83 | 15 | $435 |
| Colestipol Hcl Generic | 58 | 73 | 18 | $4,943 |
| Rabeprazole Sodium Generic | 52 | 83 | 13 | $1,625 |
| Dicyclomine Hcl Generic | 46 | 78 | 18 | $718 |
| Budesonide Dr Budesonide | 38 | 51 | 18 | $4,203 |
| Humira(Cf) Pen Adalimumab | 37 | 37 | Under 11 | $325K |
| Ursodiol Generic | 36 | 76 | Under 11 | $5,094 |
| Azathioprine Generic | 33 | 62 | Under 11 | $850 |
| Balsalazide Disodium Generic | 28 | 66 | Under 11 | $7,002 |
| Mesalamine Generic | 27 | 62 | Under 11 | $11K |
| Linzess Linaclotide | 27 | 39 | Under 11 | $21K |
Brand drugs: 384 claims; generic drugs: 1,223 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc A Scheer $2,232 ($2,232 in general payments such as food, travel and fees) from 14 companies. The largest payer was Gilead Sciences, Inc. with $491.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 24 | $491 |
| Abbvie Inc. ABBV | 21 | $342 |
| Madrigal Pharmaceuticals MDGL | 18 | $321 |
| Janssen Biotech, Inc. JNJ | 20 | $265 |
| Genzyme Corporation SNY | 8 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $218 |
| Lilly USA, LLC LLY | 4 | $89.12 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $67.46 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $62.97 |
| Ardelyx, Inc. ARDX | 3 | $49.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.